CVR Medical Corp (CRRVF)

[lakingsphan0427]

CVR Medical, Canon Sign Manufacturing Agreement for Breakthrough Device

VANCOUVER, BC / ACCESSWIRE / January 2, 2018 / CVR Medical Corp. (TSX.V: CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical”) announces the signing of a manufacturing agreement with Canon Virginia, Inc., a manufacturing, engineering and technical operation for Canon and a wholly owned subsidiary of Canon U.S.A. The agreement finalizes Canon Virginia’s status as primary manufacturer, assembler, and logistical authority for CVR’s “Carotid Stenotic Scan (CSS)” device.

CVR’s novel device, currently undergoing final phase trials at several world-renowned medical institutions, is positioned for imminent FDA submission and subsequent market launch targeted for H1 2018.

“As progress accelerates, this is a milestone which I value more than most,” CVR CEO Peter Bakema states. “Moving forward with Canon Virginia is truly the best possible outcome we planned for. Financially speaking, their breadth of in-house capabilities and supply-chain efficiencies will translate to tens of millions in short-term production and logistical cost savings. And furthermore, the Canon Virginia associations of quality, reliability and user-friendly design give the CSS immediate brand recognition that puts CVR on a trajectory to achieve our ultimate goal: change the cardiovascular healthcare landscape.”

For additional information on the organization, leadership, and current news please visit the company website www.CVRMed.com.

About CVR Medical

CVR Medical is a company that is involved in an equal parts joint venture with CVR Global Inc. (the "Joint Venture"). The Joint Venture operates in the medical industry focused on the commercialization of a proprietary subsonic, infrasonic, and low frequency sound wave analysis technology and has patents to a diagnostic device designed to detect and measure carotid arterial stenosis. CVR Medical is managed by a proven technical team. CVR Medical trades on the TSX Venture Exchange under the symbol CVM.

ON BEHALF OF THE BOARD:

(signed) "Peter Bakema"
CEO, President & Director

For further information contact:

Peter Bakema, CEO, President and Director
Telephone: [phone]
Email: [e-mail]
or
Brisco Capital Partners Corp.
Scott Koyich, President
Telephone: [phone]